CHA Biotech Co. Ltd (085660) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.063x

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has a cash flow conversion efficiency ratio of -0.063x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-64.01 Billion ≈ $-43.38 Million USD) by net assets (₩1.02 Trillion ≈ $689.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CHA Biotech Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

CHA Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how CHA Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CHA Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CHA Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SIS LIMITED NSE:SIS	0.067x
Hippo Holdings Inc NYSE:HIPO	0.019x
Nantong Guosheng Intelligence Technology Group Co Ltd SHG:688558	0.010x
Chong Kun Dang Pharmaceutical KO:185750	0.012x
Pet Acquisition LLC NASDAQ:WOOF	-0.051x
Minami Acoustics Ltd. A SHE:301383	N/A
Wuxi Xuelang Environmental Technology Co Ltd SHE:300385	0.201x
Ardmore Shipping Corporation F:A61	0.041x

Annual Cash Flow Conversion Efficiency for CHA Biotech Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of CHA Biotech Co. Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see 085660 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩809.25 Billion ≈ $548.42 Million	₩-72.52 Billion ≈ $-49.15 Million	-0.090x	+48.51%
2024-12-31	₩284.69 Billion ≈ $192.93 Million	₩-49.55 Billion ≈ $-33.58 Million	-0.174x	-1092.29%
2023-12-31	₩656.33 Billion ≈ $444.79 Million	₩11.51 Billion ≈ $7.80 Million	0.018x	+124.80%
2022-12-31	₩291.73 Billion ≈ $197.70 Million	₩-20.63 Billion ≈ $-13.98 Million	-0.071x	-245.08%
2021-12-31	₩456.06 Billion ≈ $309.06 Million	₩22.23 Billion ≈ $15.06 Million	0.049x	-63.17%
2020-12-31	₩355.09 Billion ≈ $240.64 Million	₩47.00 Billion ≈ $31.85 Million	0.132x	+97.78%
2019-12-31	₩377.18 Billion ≈ $255.61 Million	₩25.24 Billion ≈ $17.10 Million	0.067x	-70.97%
2018-12-31	₩326.99 Billion ≈ $221.60 Million	₩75.38 Billion ≈ $51.09 Million	0.231x	+342.94%
2017-12-31	₩230.74 Billion ≈ $156.37 Million	₩12.01 Billion ≈ $8.14 Million	0.052x	+31.95%
2016-12-31	₩286.32 Billion ≈ $194.04 Million	₩11.29 Billion ≈ $7.65 Million	0.039x	-81.50%
2015-12-31	₩290.10 Billion ≈ $196.60 Million	₩61.86 Billion ≈ $41.92 Million	0.213x	+3732.73%
2014-12-31	₩437.45 Billion ≈ $296.46 Million	₩-2.57 Billion ≈ $-1.74 Million	-0.006x	-104.53%
2013-12-31	₩512.34 Billion ≈ $347.21 Million	₩66.35 Billion ≈ $44.97 Million	0.130x	-6.23%
2012-12-31	₩331.41 Billion ≈ $224.59 Million	₩45.77 Billion ≈ $31.02 Million	0.138x	+13.63%
2011-12-31	₩285.46 Billion ≈ $193.45 Million	₩34.69 Billion ≈ $23.51 Million	0.122x	-54.29%
2010-12-31	₩158.24 Billion ≈ $107.24 Million	₩42.07 Billion ≈ $28.51 Million	0.266x	+39.05%
2009-12-31	₩125.61 Billion ≈ $85.12 Million	₩24.02 Billion ≈ $16.28 Million	0.191x	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$651.56 Million

₩961.44 Billion KRW

Market Cap Rank

#11098 Global

#306 in Korea

Share Price

₩12580.00

Change (1 day)

+1.78%

52-Week Range

₩10120.00 - ₩23850.00

All Time High

₩40950.00